March 2020 - Page 3 of 3 - Dr. Rath Health Foundation

March 6, 2020

Published by Paul Anthony Taylor at March 6, 2020

Categories

Chinese Medical Team Report Successful Treatment Of Coronavirus Patients With High-Dose Vitamin C

A medical team from the Second Affiliated Hospital of Xi’an Jiaotong University in China has reported the successful treatment of coronavirus patients with vitamin C. In […]

March 5, 2020

Published by Dr. Rath Health Foundation at March 5, 2020

Categories

News & Comment

Air Pollution Reducing Global Life Expectancy By Three Years And Killing 8.8 Million People A Year

NEWS Air pollution is reducing global life expectancy by three years and killing 8.8 million people a year, a new study shows. COMMENT Studies show that […]

March 5, 2020

Published by Dr. Rath Health Foundation at March 5, 2020

Categories

News & Comment

Drug Company Novartis Fined $195 Million Following Criminal Collusion In Price-Fixing Scheme

NEWS Sandoz, the generic drug unit of pharmaceutical giant Novartis, has admitted it colluded with other companies to inflate the prices of generic drugs and is […]

March 5, 2020

Published by Dr. Rath Health Foundation at March 5, 2020

Categories

News & Comment

Low Folate Levels Linked To Raised Risk Of Death From Cardiovascular Disease In Rheumatoid Arthritis Patients

NEWS Decreased folate levels in the bloodstream are associated with an increased risk of death from cardiovascular disease in patients with rheumatoid arthritis, finds a new […]

March 5, 2020

Published by Dr. Rath Health Foundation at March 5, 2020

Categories

News & Comment

Anti-Psychotic Drug Linked To Adverse Changes In Brain Structure

NEWS A new study has found that olanzapine, a commonly used anti-psychotic drug, is associated with potentially adverse changes in brain structure. COMMENT Not only do […]

March 5, 2020

Published by Dr. Rath Health Foundation at March 5, 2020

Categories

News & Comment

Bayer Chairman Resigns After Disastrous Takeover Of Monsanto

NEWS Bayer Chairman Werner Wenning, one of the architects of the $63 billion takeover of Monsanto that has left the German pharma company fighting tens of […]